Literature DB >> 26994048

Lithium toxicity after Roux-en-Y bariatric surgery.

Deanna Musfeldt1, Andrew Levinson2, Jennifer Nykiel3, Gerardo Carino2.   

Abstract

A 61-year-old woman with medical history significant for morbid obesity, type II diabetes mellitus, nephrogenic diabetes insipidus and bipolar disorder, had been stable on lithium carbonate therapy for several years. She had undergone a Roux-en-Y bypass surgery and, at the time of her surgery, her lithium level was found to be 0.61 mEq/L on a maintenance dose of 600 mg orally twice per day. She was discharged 8 days postoperatively on the same lithium dose, but presented to the emergency department 12 days postoperatively with signs of lithium toxicity. Her lithium level was elevated to 1.51 mEq/L and she was treated for lithium toxicity with supportive care and, ultimately, reduction of her lithium dose. Clinicians should be aware that dramatic and poorly understood changes in drug absorption may occur after bariatric surgery. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26994048      PMCID: PMC4800199          DOI: 10.1136/bcr-2015-214056

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

1.  American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient.

Authors:  Jeffrey I Mechanick; Robert F Kushner; Harvey J Sugerman; J Michael Gonzalez-Campoy; Maria L Collazo-Clavell; Safak Guven; Adam F Spitz; Caroline M Apovian; Edward H Livingston; Robert Brolin; David B Sarwer; Wendy A Anderson; John Dixon
Journal:  Surg Obes Relat Dis       Date:  2008-08-19       Impact factor: 4.734

Review 2.  Nutrition management of the post-bariatric surgery patient.

Authors:  Gabriela Handzlik-Orlik; Michał Holecki; Bartłomiej Orlik; Mariusz Wyleżoł; Jan Duława
Journal:  Nutr Clin Pract       Date:  2014-12-29       Impact factor: 3.080

Review 3.  Vitamin, mineral, and drug absorption following bariatric surgery.

Authors:  Ronald Andari Sawaya; Jane Jaffe; Lindsay Friedenberg; Frank K Friedenberg
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

4.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

5.  Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients.

Authors:  I B Skottheim; K Stormark; H Christensen; G S Jakobsen; J Hjelmesaeth; T Jenssen; J L E Reubsaet; R Sandbu; A Asberg
Journal:  Clin Pharmacol Ther       Date:  2009-06-03       Impact factor: 6.875

6.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

7.  Dose-adjusted cyclosporine c2 in a patient with jejunoileal bypass as compared to seven other liver transplant recipients.

Authors:  Rou-Yee Chenhsu; Youmin Wu; Daniel Katz; Stephen Rayhill
Journal:  Ther Drug Monit       Date:  2003-12       Impact factor: 3.681

8.  A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters.

Authors:  H J Sugerman; J V Starkey; R Birkenhauer
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

9.  Bariatric surgery in 1119 patients with preoperative body mass index<35 (kg/m(2)): results at 1 year.

Authors:  Cristóbal Maiz; Juan Alvarado; Nicolás Quezada; José Salinas; Ricardo Funke; Camilo Boza
Journal:  Surg Obes Relat Dis       Date:  2015-03-27       Impact factor: 4.734

10.  Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy.

Authors:  Diana M Sobieraj; Fei Wang; Orlando C Kirton
Journal:  Pharmacotherapy       Date:  2008-12       Impact factor: 4.705

View more
  5 in total

1.  Systematic review of drug bioavailability following gastrointestinal surgery.

Authors:  Manuela Moreno Santamaría; José Javier Arenas Villafranca; Jimena Abilés; Alberto Fernández López; Lucia Visiedo Rodas; Begoña Tortajada Goitia; Pilar Utrilla Navarro
Journal:  Eur J Clin Pharmacol       Date:  2018-08-22       Impact factor: 2.953

Review 2.  Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the Literature.

Authors:  Arik Dahan; Daniel Porat; Carmil Azran; Yoni Mualem; Nasser Sakran; Subhi Abu-Abeid
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

3.  Lithium toxicity following Roux-en-Y gastric bypass: Mini review and illustrative case.

Authors:  Shahana Ayub; Sundas Saboor; Sadia Usmani; Sana Javed; Gauvain Kankeu Tonpouwo; Saeed Ahmed
Journal:  Ment Health Clin       Date:  2022-06-10

Review 4.  Oral drug dosing following bariatric surgery: General concepts and specific dosing advice.

Authors:  Jurjen S Kingma; Desirée M T Burgers; Valerie M Monpellier; Marinus J Wiezer; Heleen J Blussé van Oud-Alblas; Janelle D Vaughns; Catherine M T Sherwin; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2021-06-03       Impact factor: 3.716

Review 5.  Lithium toxicity with prolonged neurologic sequelae following sleeve gastrectomy: A case report and review of literature.

Authors:  Yi-Hsin Lin; Sheng-Wen Liu; Hsein-Lin Wu; Jung-Cheng Kang; Kuo-Yang Huang; Hsuan Huang
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.